Aim Bulletin
Reach4entertainment subsidiaries agree fresh deals with Miroma
Entertainment marketing communications group Reach4entertainment Enterprises announced on Thursday that its subsidiaries Dewynters, and Spot and Company of Manhattan, have renewed their existing media buying agreements with Miroma International and Miroma Outcomes, respectively.
Lok'nStore agrees new £75m facility to fund new store development
Self storage provider Lok'nStore announced the agreement of a new £75m five-year revolving credit facility on Thursday, which would replace its existing £50m facility and provide funding for site acquisitions and development, to support the group's growth plans.
Range Resources settles all outstanding claims in Colombia
Trinidad and Indonesia-focussed oil and gas company Range Resources announced on Thursday that the court in Colombia had approved the decision to settle all outstanding historic claims and disputes between Agencia Nacional de Hidrocarburos (ANH) and the consortium of Range and Optima Oil Corporation.
Synnovia discovers non-material overstatement of revenues, reports strong growth
Industrial components manufacturer Synnovia recently discovered a non-material overstatement of revenues linked to its trading year ended 31 March 2018.
Mincon revenues soar as sales of own-brand products increase
Irish engineering group Mincon saw own-brand sales increase in the first quarter of its trading year, resulting in improved revenues for the group as a whole.
Verditek partners with Engenera to advance solar projects
Verditek on Thursday signed a framework agreement with Engenera Renewables to advance commercial opportunities and jointly provide end-to-end solar solutions to clients.
Scancell gets go-ahead for UK second phase trials of 'SCIB1'
Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of ‘SCIB1’ in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Water Intelligence anticipates H1 boost from North America contract wins
Water Intelligence on Thursday said it was optimistic for a "strong" first half of the year following contract wins in the US and Canada by its subsidiary, Water Intelligence International Limited (WII), including a contract in Flint, Michigan.
Allergy Therapeutics eyes 2020 start for hay fever inoculation trials
Commercial biotechnology company Allergy Therapeutics will kick off phase III trials of its short-course inoculation for grass pollen-induced hay fever in the second half of 2020 following a successful round of meetings with German and American regulatory bodies.
Image Scan Holdings soars despite taking revenue hit
Image Scan Holdings shares leapt on Thursday after the company said it expects to meet full year expectations despite disappointing first-half sales.
Feedback expects 'significant growth' in revenues
Medical imaging technology outfit Feedback expects to report significant growth in revenues throughout its current trading year.
Ixico revenues on track to meet full-year market expectations
Data analytics firm Ixico expects half-year revenues to be in line with market expectations.
NetScientific CEO stands down to assist with cost reduction efforts
NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.